Stoke Therapeutics, Inc. ($STOK)
Filing Information
| Accession Number | 0001774690-26-000006 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 19, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
4,578
Total Value
$147,144.94
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Common Stock | โ | Mar 17, 2026 | Sale | 1,274 | $32.74 | $41,710.00 | 13,476 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Mar 17, 2026 | Sale | 922 | $33.38 | $30,772.12 | 12,554 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Mar 18, 2026 | Sale | 2,173 | $31.28 | $67,979.70 | 10,381 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Mar 18, 2026 | Sale | 172 | $31.79 | $5,467.67 | 10,209 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Mar 18, 2026 | Sale | 37 | $32.85 | $1,215.45 | 10,172 | Direct | โ | View Details |